See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2018_Biomarin_Pharmaceutical_INC.pdf
Logs
Graph
Absolute values for 0001048477, Biomarin Pharmaceutical INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,207,144,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 714,549,000 |
| 2 | PropertyPlantAndEquipmentNet | 896,700,000 |
| 3 | remainder_Assets | 814,732,000 |
| 4 | LiabilitiesCurrent | 816,518,000 |
| 5 | LiabilitiesNoncurrent | 59,105,000 |
| 6 | remainder_Liabilities | 948,839,000 |
| 7 | CostOfGoodsAndServicesSold | 273,396,997 |
| 8 | SellingGeneralAndAdministrativeExpense | 662,513,763 |
| 9 | ResearchAndDevelopmentExpense | 538,393,502 |
| 10 | remainder_Expenses | 770,292,799 |
| 11 | remainder_Revenues | -1,112,910,483 |
| 12 | remainder_NetIncome | 20,637,969 |
| 13 | remainder_ComprehensiveNetIncome | -30,905,556 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,633,125,000 |
| 1 | Liabilities | 1,824,462,000 |
| 2 | Expenses | 2,244,597,061 |
| 3 | Revenues | -1,112,910,483 |
| 4 | StockholdersEquity | 2,808,663,000 |
| 5 | NetIncome | -3,336,869,575 |
| 6 | ComprehensiveNetIncome | -3,352,322,353 |
| 7 | BaseVar | 4,933,319,034 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.858 |
| 9 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
